-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Equal-Weight on Amphastar Pharma, Raises Price Target to $25

Benzinga·11/06/2026 14:47:59
Listen to the news
Wells Fargo analyst Benjamin Burnett maintains Amphastar Pharma (NASDAQ:AMPH) with a Equal-Weight and raises the price target from $20 to $25.